CERo Therapeutics Holdings, Inc. Common Stock
Symbol: CERO (NASDAQ)
5.10
▼ (-5.28%) -0.284
Company Description:
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
Key Stats
- Today's Open: $5.38
- Today's High: $5.568
- Today's Low: $5.04
- Today's Volume: 296.52K
- Yesterday Close: $5.38
- Yesterday High: $5.45
- Yesterday Low: $5.3
- Yesterday Volume: 98.98K
- Last Min Volume: 791
- Last Min High: $5.141
- Last Min Low: $5.096
- Last Min VWAP: $5.10505
Company Profile
- Name: CERo Therapeutics Holdings, Inc. Common Stock
- Website: https://www.cero.bio
- Listed Date: 2024-02-15
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001870404
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $6.50M
- Round Lot: 100
- Outstanding Shares: 1.21M
- Asset Type: CS
RECENT FILINGS FOR CERO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-22 | 8-K | View |
| 2025-09-05 | 424B3 | View |
| 2025-09-05 | 424B3 | View |
| 2025-09-05 | 8-K | View |
| 2025-09-04 | 424B3 | View |
| 2025-09-04 | 424B3 | View |
| 2025-09-04 | 8-K | View |
| 2025-08-22 | 424B3 | View |
| 2025-08-22 | 424B3 | View |
| 2025-08-22 | 10-Q | View |
| 2025-08-15 | EFFECT | View |
| 2025-08-15 | NT 10-Q | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | CORRESP | View |
| 2025-08-14 | UPLOAD | View |
| 2025-08-11 | S-3 | View |
| 2025-07-29 | EFFECT | View |
| 2025-07-28 | S-8 | View |
| 2025-07-28 | CORRESP | View |
| 2025-07-25 | 424B3 | View |
Latest News on CERO